Notably, more than 50% of the peripheral blood B cells in the patient had a DN (CD19+IgD–CD27–) phenotype (Figure 3D), a population previously found to be increased in patients with autoimmune diseases and in elderly individuals (22). This evidence concerns the gene CD19 and autoimmune disease.